ÂÜÀòÂÒÂ×

Jason A. Amello is a seasoned financial executive with extensive experience in the biotechnology and healthcare sectors. Currently serving as Chief Financial Officer and Treasurer at TScan Therapeutics since January 2024, Amello previously held similar roles at Candel Therapeutics and Saniona, among others. Notably, Amello contributed to the Board of Directors for Acer Therapeutics and New England Baptist Hospital, where committee leadership included chairing the Audit Committee and the Quality of Care Committee. With a foundation in finance and accounting from Boston College, Amello is a Certified Public Accountant in Massachusetts and has held senior financial positions at various organizations, including Genzyme Corporation and Akebia Therapeutics, where responsibilities encompassed strategic financial management and corporate controllership.